KBC Group NV boosted its stake in AmerisourceBergen Corp. (NYSE:ABC) by 30.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 26,480 shares of the company’s stock after purchasing an additional 6,156 shares during the quarter. KBC Group NV’s holdings in AmerisourceBergen were worth $2,431,000 as of its most recent SEC filing.
Other large investors also recently bought and sold shares of the company. Vantage Investment Advisors LLC acquired a new stake in AmerisourceBergen in the fourth quarter worth $156,000. Intl Fcstone Inc. acquired a new stake in AmerisourceBergen in the second quarter worth $201,000. TRUE Private Wealth Advisors acquired a new stake in AmerisourceBergen in the fourth quarter worth $203,000. Zeke Capital Advisors LLC acquired a new stake in AmerisourceBergen in the third quarter worth $210,000. Finally, Roberts Glore & Co. Inc. IL acquired a new stake in AmerisourceBergen in the third quarter worth $219,000. Institutional investors and hedge funds own 65.98% of the company’s stock.
AmerisourceBergen Corp. (ABC) opened at $99.94 on Wednesday. AmerisourceBergen Corp. has a 12 month low of $71.90 and a 12 month high of $106.27. The firm has a market cap of $21,835.10, a price-to-earnings ratio of 16.35, a price-to-earnings-growth ratio of 1.59 and a beta of 1.02. The company has a quick ratio of 0.50, a current ratio of 0.95 and a debt-to-equity ratio of 1.61.
The company also recently declared a quarterly dividend, which will be paid on Monday, March 5th. Investors of record on Tuesday, February 20th will be given a dividend of $0.38 per share. This represents a $1.52 dividend on an annualized basis and a dividend yield of 1.52%. The ex-dividend date of this dividend is Friday, February 16th. AmerisourceBergen’s payout ratio is currently 32.76%.
In related news, Chairman Steven H. Collis sold 21,350 shares of the firm’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $82.53, for a total transaction of $1,762,015.50. Following the transaction, the chairman now directly owns 287,925 shares of the company’s stock, valued at $23,762,450.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Dale Danilewitz sold 21,500 shares of the firm’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $97.30, for a total transaction of $2,091,950.00. The disclosure for this sale can be found here. Insiders have sold 222,396 shares of company stock worth $20,261,915 over the last three months. 27.30% of the stock is owned by insiders.
A number of equities research analysts have commented on ABC shares. Mizuho set a $92.00 price target on shares of AmerisourceBergen and gave the stock a “hold” rating in a report on Tuesday, October 24th. Zacks Investment Research raised shares of AmerisourceBergen from a “hold” rating to a “buy” rating and set a $105.00 price objective on the stock in a research note on Wednesday, January 3rd. Deutsche Bank initiated coverage on shares of AmerisourceBergen in a research note on Monday, December 4th. They issued a “buy” rating and a $97.00 price objective on the stock. Goldman Sachs Group raised shares of AmerisourceBergen from a “neutral” rating to a “buy” rating in a research note on Friday, December 15th. Finally, Leerink Swann set a $105.00 price objective on shares of AmerisourceBergen and gave the company a “buy” rating in a research note on Tuesday, January 2nd. One analyst has rated the stock with a sell rating, six have assigned a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. AmerisourceBergen has a consensus rating of “Buy” and an average price target of $101.17.
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.